the efficiency controls show that the increase of platelets in the peripheral blood , which is most critical in advanced hcl , may be seen earlier by this than by other protocols , which usually recommend higher daily doses of ifn and only three instead of five weekly applications .
C0005821
platelets
C0229664
peripheral blood